BMPR2 antibody from Promab.
Know who made it. See the evidence. Buy through one marketplace.
On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. BMPR2 can also mediate signalling through the activation of the p38MAPK cascade.
For research use only.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC | IHC-P | IHC-F | IF/ICC | Flow Cytometry | ELISA | IP | ChIP |
|---|---|---|---|---|---|---|---|---|---|
| Human | |||||||||
| Mouse |
This product is manufactured by Promab and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
BMPR2 (bone morphogenetic protein receptor type 2; BMPR-II/BMPR-2) is a type II transmembrane serine/threonine kinase receptor in BMP signalling. In ligand-induced receptor complexes, BMPR2 activates type I BMP receptors, enabling downstream SMAD transcriptional responses.
Biological function: BMPR2 is a type II receptor serine/threonine kinase that binds BMP-family ligands including BMP2 and BMP7. Upon ligand-dependent receptor-complex formation, BMPR2 phosphorylates and activates type I BMP receptors; activated type I receptors then engage SMAD transcriptional regulators. Curated UniProt evidence also supports non-canonical signalling through the p38 MAPK cascade in defined contexts.